Product correctly added to cart.

discount label
Cyclohexylzinc Bromide Solution
View 3D

Biosynth logo

Cyclohexylzinc Bromide Solution

CAS: 7565-57-3

Ref. 3D-HAA56557

10mlTo inquire
25mlTo inquire
50mlTo inquire
100mlTo inquire
250mlTo inquire
Estimated delivery in United States, on Thursday 23 Jan 2025

Product Information

Name:
Cyclohexylzinc Bromide Solution
Description:

Cyclohexylzinc Bromide Solution is a chemical substance that is used in cancer therapy. Cyclohexylzinc Bromide Solution has been shown to have anticancer activity and can be used to treat skin conditions. The drug also has immunosuppressant properties, which may be useful for the treatment of colitis and other inflammatory bowel diseases. Cyclohexylzinc Bromide Solution is metabolized by the liver, with a significant amount excreted in urine. It's pharmacokinetics are linear over a wide range of doses and it does not interact with other drugs or food products. This drug has no effect on the central nervous system and can be used as part of chemotherapy treatments for cancers such as leukemia, lymphoma, and breast cancer.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
228.44 g/mol
Formula:
C6H11BrZn
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-HAA56557 Cyclohexylzinc Bromide Solution

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".